# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Dorothea Lange (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML045-SYN
- Date: 2026-05-18
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gwendolyn Ashford-Mensah, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Endoscopy results; post-polio syndrome follow-up. **S**

## History of present illness

Ms. Lange had an upper endoscopy two and a half weeks ago, three and a half weeks after her last omeprazole dose, under moderate sedation at reduced doses with oxygen and carbon dioxide monitoring and warming; she recovered without any fall in oxygen saturation. It showed Los Angeles grade B esophagitis and a 2 cm sliding hiatal hernia, with a regular junction and no Barrett's esophagus; the stomach showed healed changes of her ulcer operation and no ulcer, and the gastric biopsies showed no Helicobacter pylori. The fever and aching after the zoledronic acid infusion settled in three days. Heartburn continues on four or five nights a week on antacid tablets. Physical therapy ends next week; she has learned her home program. No falls. She is printing in the darkroom for an exhibition and photographing two days a week. **S**

| Element | Detail |
|---|---|
| Endoscopy | LA grade B esophagitis; 2 cm hiatal hernia; no Barrett's esophagus; no Helicobacter pylori |
| Sedation | Reduced doses tolerated without desaturation |
| After zoledronic acid | Acute-phase reaction for three days, resolved |
| Function | No falls; physical therapy ending next week |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; weight stable |
| Gastrointestinal | Positive | Heartburn four or five nights a week; no difficulty swallowing, vomiting, or black stools |
| Musculoskeletal | Positive | Mild thigh aching after field days |
| Neurological | Negative | No new weakness |
| Respiratory | Negative | No breathlessness |
| Psychiatric | Negative | Mood good; PHQ-9 3 |

6 systems reviewed. **S**

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for muscle aching, no more than 3000 mg a day **S**
- Cholecalciferol (vitamin D3) 1000 units oral tablet, two tablets (2000 units) by mouth once daily **S**
- Zoledronic acid 5 mg in 100 mL intravenous infusion over at least 15 minutes once a year **S**
- Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth before breakfast for eight weeks to heal esophagitis, then the lowest dose that controls symptoms **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/74 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 50.8 kg; BMI 22 kg/m². All vital signs are synthetic.

PHQ-9: 3; Pain (0 to 10): 4. All results are synthetic.

## Change since baseline

- PHQ-9: 6 at baseline, 3 at this visit **S**
- Pain (0 to 10): 6 at baseline, 4 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Abdomen | Soft; no tenderness |
| Neurological | Strength unchanged: left quadriceps 4/5, right quadriceps 3+/5 |
| Gait | Steady with the orthosis and cane; Timed Up and Go 11.5 seconds |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Reflux esophagitis, Los Angeles grade B** (K21.00). Grade B esophagitis with typical symptoms that responded to a proton pump inhibitor establishes the diagnosis of reflux disease. There is no Barrett's esophagus, and she does not have the three or more risk factors that would call for Barrett's screening, so after this negative examination no surveillance endoscopy is needed. No Helicobacter pylori. **S**
   - Omeprazole 20 mg before breakfast for eight weeks to heal the esophagitis, then step down to the lowest dose that controls symptoms.
   - No meals within three hours of bed; raise the head of the bed; limit late wine and large evening meals.
   - Report difficulty swallowing, food sticking, weight loss, vomiting, or black stools at once.
2. **Small sliding hiatal hernia** (K44.9). Contributes to reflux; no treatment beyond the reflux measures. **S**
   - No surgery needed.
3. **Post-polio syndrome** (G14). Stable strength; pain 4 of 10; no falls. The infusion reaction did not affect her strength. **S**
   - Home exercise program four days a week after physical therapy ends.
   - Continue pacing and the orthosis.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Upper endoscopy off proton pump inhibitor | When symptoms return after stopping | Up to date | Two and a half weeks ago: LA grade B esophagitis; 2 cm hiatal hernia; no Barrett's esophagus |
| Laboratory | Gastric biopsies for Helicobacter pylori | At endoscopy | Up to date | Negative |
| Imaging | Barrett's esophagus surveillance | Only if Barrett's esophagus is found | Not indicated | None found; fewer than three risk factors; no repeat screening after a negative examination |
| Medication safety | Proton pump inhibitor dose | Healing course, then the lowest effective dose | Completed today | Omeprazole 20 mg daily for eight weeks; step-down planned |
| Self-management | Reflux lifestyle measures | Every visit | Completed today | Last meal three hours before bed; head of bed raised |
| Medication safety | Sedation precautions | Before any procedure | Up to date | Endoscopy under reduced-dose sedation without desaturation |
| Examination | Manual muscle testing and Timed Up and Go | Every visit | Completed today | Strength unchanged; TUG 11.5 seconds |
| Survey | Pain score | Every visit | Completed today | Pain 4 of 10 |
| Survey | Depression screen (PHQ-9) | Periodically | Completed today | PHQ-9 3 |
| Referral | Supervised non-fatiguing exercise (physical therapy) | Twelve weeks | Up to date | Ends next week; home program learned |
| Examination | Swallowing screen | Every visit | Completed today | No difficulty swallowing |
| Examination | Fall review | Every visit | Completed today | No falls |
| Medication safety | Zoledronic acid tolerance | After each infusion | Completed today | Acute-phase reaction for three days after the first dose; calcium normal at the sick visit |
| Laboratory | 24-hour urine calcium | At diagnosis | Due | Kit reissued; to be collected before the yearly review |

## Goal progress

- Find the cause of the new weakness and fatigue within four weeks, with other treatable causes excluded. Outcome by 2026-02-25: Post-polio syndrome diagnosed at 16 days after the tests excluded thyroid disease, anemia, diabetes, B12 deficiency, neuropathy, and myopathy. **S**
- No falls over the next six months. In progress; target 2026-08-17. **S**
- Keep working in the field at least two days a week, with planned rests, without exhaustion the next day. In progress; target 2026-12-31. **S**
- Establish the cause of the heartburn and control it on the lowest effective therapy. Outcome by 2026-05-18: Endoscopy showed grade B esophagitis without Barrett's esophagus; omeprazole restarted, symptoms controlled. **S**
- Replete vitamin D and start fracture-protective treatment. Outcome by 2026-04-20: Vitamin D 34 ng/mL; first zoledronic acid infusion given. **S**

## Medication changes

- Stopped: Calcium carbonate 500 mg chewable tablet, one or two tablets by mouth as needed for heartburn, no more than six tablets a day, while off omeprazole before the endoscopy **S**
- Started: Omeprazole 20 mg delayed-release oral capsule, one capsule by mouth before breakfast for eight weeks to heal esophagitis, then the lowest dose that controls symptoms **S**

## Guideline basis

- EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801 (2006), European Federation of Neurological Societies
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022;117(1):27-56 (2022), American College of Gastroenterology
- Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117(4):559-587 (2022), American College of Gastroenterology

## Follow-up

- Omeprazole for eight weeks, then step down. Primary care review in three months. **S**
- Next scheduled visit 2026-08-17: six-month review of post-polio syndrome, falls, bone health, and reflux step-down. **S**
